GHK-Cu

No. There are zero human clinical trials of injectable GHK-Cu and no established dose. Everything about subcutaneous use is community/biohacker practice framed as research-use-only. The real human evidence for GHK-Cu is topical (cosmetic anti-aging), not injected.

Topical GHK-Cu is a mainstream cosmetic ingredient (INCI: Copper tripeptide-1) with actual human data behind it, usually at 1-3% in serums and creams applied once or twice daily. Injectable use has no trials, no approved dose, and adds a copper-load concern because injection bypasses the gut's copper regulation. If you want the evidence-backed route, that's topical.

It's a legitimate theoretical concern for injectable use specifically. Oral copper is tightly regulated by the gut; subcutaneous injection skips that, so repeated systemic dosing could accumulate copper. That's why community protocols run 4-8 week cycles with 4-6 week off-periods. Topical application doesn't carry the same systemic load. Anyone with a copper-metabolism disorder should avoid GHK-Cu entirely.

No. GHK-Cu is contraindicated in Wilson's disease and any other copper-metabolism disorder, because the whole point of the molecule is to bind and deliver copper. If you have a copper-handling condition, don't use it in any form.

Use bacteriostatic water. A 50 mg vial plus 2 mL BAC water gives 25 mg/mL, so 250 mcg is 0.01 mL (1 unit on a U-100 insulin syringe) and 500 mcg is 0.02 mL (2 units). Keep the reconstituted vial refrigerated. This is reference information for research use, not a prescription.

Common community pairings (none clinically validated) include BPC-157 and TB-500 for tissue repair, KPV for anti-inflammatory support, and epithalon for anti-aging protocols. Topically it's often combined with microneedling to boost delivery, and hair users add minoxidil, finasteride, or RU-58841. Avoid layering GHK-Cu with strong acids, retinoids, or high-dose vitamin C in the same session, since those can break the copper complex apart.

For topical use, most reported changes in texture and firmness show up over 8-12+ weeks of consistent daily application, and benefits fade if you stop. For injectable use there's no reliable timeline because there's no clinical data; any reported effects are anecdotal and unverified.

Circulating GHK runs around 200 ng/mL in your early twenties and falls to roughly 80 ng/mL by age 60, and the peptide influences collagen, antioxidant genes, and a large gene-expression signature in lab studies (PMID: 25302294). That age-related decline plus the mechanistic data is the basis for the anti-aging interest, though the systems-level gene findings come from cell lines and aren't proven clinical outcomes in people.

That pattern (acne, cracked mouth corners, a sore tongue, or extra shedding) often points to zinc running low. GHK-Cu delivers copper, copper and zinc balance each other, and building collagen also pulls on your zinc stores, so if yours were borderline the extra demand shows up as those symptoms. The usual move is to check a zinc/copper/ceruloplasmin panel and add zinc (many use zinc bisglycinate). If it does not settle, GHK-Cu may just not be for you. Not medical advice.

It can. Your body makes GHK on its own, levels are highest when you are young and start dropping in the mid-30s, faster for some people than others. Users past about 40 tend to notice more, while a lot of under-40 users report more side effects and less benefit because their own GHK is still high. If you are young and healthy, you may simply not need it.

You often do not without testing. Independent labs have reported GHK-Cu vials running anywhere from 30% to 95% underdosed, and because it is a copper compound, heavy-metal contamination is worth screening too. If you are going to run it, test for dose accuracy and heavy metals, and buy from sources that test their material.